Evangelos Giamarellos-Bourboulis to Anti-Bacterial Agents
This is a "connection" page, showing publications Evangelos Giamarellos-Bourboulis has written about Anti-Bacterial Agents.
Connection Strength
0.568
-
A prognostic score for the resolution of bacteremia by Gram-negative bacteria resistant to carbapenems. Eur J Clin Microbiol Infect Dis. 2018 Nov; 37(11):2083-2089.
Score: 0.155
-
Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical Trial. JAMA. 2018 02 27; 319(8):788-799.
Score: 0.150
-
Pharmacological management of sepsis in adults with a focus on the current gold standard treatments and promising adjunctive strategies: evidence from the last five years. Expert Opin Pharmacother. 2019 06; 20(8):991-1007.
Score: 0.040
-
Daptomycin as adjunctive treatment for experimental infection by Acinetobacter baumannii with resistance to colistin. Int J Antimicrob Agents. 2019 Feb; 53(2):190-194.
Score: 0.039
-
Early increase of VEGF-A is associated with resolution of ventilator-associated pneumonia: Clinical and experimental evidence. Respirology. 2018 10; 23(10):942-949.
Score: 0.038
-
Low-dose hydrocortisone prolongs survival in a lethal sepsis model in adrenalectomized rats. J Surg Res. 2018 07; 227:72-80.
Score: 0.038
-
Pharmacokinetic/Toxicodynamic Analysis of Colistin-Associated Acute Kidney Injury in Critically Ill Patients. Antimicrob Agents Chemother. 2017 11; 61(11).
Score: 0.037
-
Efficacy of intramuscular moxifloxacin in the treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents. 2017 Aug; 50(2):186-190.
Score: 0.036
-
Dosing guidance for intravenous colistin in critically-ill patients. Clin Infect Dis. 2017 03 01; 64(5):565-571.
Score: 0.035